锌转运体ZIP13与疾病

doi:10.16352/j.issn.1001-6325.2024.12.1712

基础医学与临床 ›› 2024, Vol. 44 ›› Issue (12): 1712-1716.doi: 10.16352/j.issn.1001-6325.2024.12.1712

锌转运体ZIP13与疾病

李欢欢, 马婧, 邓佩佩, 刘璇, 王树松^*

河北省生殖健康医院河北省生殖医学重点实验室,河北石家庄 050071

收稿日期:2023-12-20 修回日期:2024-05-11 出版日期:2024-12-05 发布日期:2024-11-26
通讯作者: ^*wshsong@126.com
基金资助:
河北省自然科学基金(H2022314001);河北省医学科学研究课题计划(20231201);2022年河北省政府资助临床优秀人才项目

Zinc transporter ZIP13 and diseases

LI Huanhuan, MA Jing, DENG Peipei, LIU Xuan, WANG Shusong^*

Hebei Key Laboratory of Reproductive Medicine, Hebei Reproductive Health Hospital, Shijiazhuang 050071, China

Received:2023-12-20 Revised:2024-05-11 Online:2024-12-05 Published:2024-11-26
Contact: ^*wshsong@126.com

摘要/Abstract

摘要： 锌是蛋白质合成、细胞增殖、迁移和自噬等多种生物过程的重要调节因子。锌转运体ZIP13(SLC39A13)是一种同源二聚体的金属转运蛋白,参与机体锌、铁和钙等离子的转运。ZIP13通过调节锌稳态参与疾病调控,如ZIP13 在结缔组织发育中的关键作用至少部分是因为它参与了 BMP/TGF-β 信号通路,ZIP13 通过激活 Src/FAK 信号通路促进人卵巢癌细胞的转移和ZIP13 通过调节 C/EBP-β 表达来抑制米色脂肪细胞的生物发生和能量消耗等。

关键词: 锌转运体, ZIP13, Ehlers-Danlos综合症, 金属离子转运

Abstract: Zinc is an important regulator of various biological processes such as protein synthesis, cell proliferation, migration and autophagy. The zinc transporter ZIP13 (SLC39A13) is a homodimeric metal transporter functioning in transport of zinc, iron, and calcium plasma in body. ZIP13 is involved in disease by regulating zinc homeostasis, such as the key role of ZIP13 in connective tissue development because it is involved in the BMP/TGF-β signaling pathway. ZIP13 promotes the metastasis of human ovarian cancer cells by activating the Src/FAK signaling pathway and ZIP13 inhibits the biogenesis and energy expenditure of beige adipocytes by regulating C/EBP-β expression.

Key words: zinc transporter, ZIP13, Ehlers-Danlos syndrome, ion transport

中图分类号:

R363

李欢欢, 马婧, 邓佩佩, 刘璇, 王树松. 锌转运体ZIP13与疾病[J]. 基础医学与临床, 2024, 44(12): 1712-1716.

LI Huanhuan, MA Jing, DENG Peipei, LIU Xuan, WANG Shusong. Zinc transporter ZIP13 and diseases[J]. Basic & Clinical Medicine, 2024, 44(12): 1712-1716.

参考文献

[1]Sofia B, Mi-Gi L, Bum-Ho B, et al. Zinc and its transporters in epigenetics[J]. Molecules Cells, 2020, 43:323-330.
[2]Zhao M, Zhou B. A distinctive sequence motif in the fourth transmembrane domain confers ZIP13 iron function in Drosophila melanogaster[J]. Biochim Biophys Acta Mol Cell Res, 2020, 1867:118607. doi: 10.1016/j.bbamcr.2019.118607.
[3]Xue J, Li G, Ji X, et al. Drosophila ZIP13 over-expression or transferrin1 RNAi influences the muscle degeneration of Pink1 RNAi by elevating iron levels in mitochondria[J]. J Neurochem, 2022, 160:540-555.
[4]Liu SZ, Xu YC, Tan XY, et al. Transcriptional regulation and protein localization of Zip10, Zip13 and Zip14 transporters of freshwater teleost yellow catfish pelteobagrus fulvidraco following Zn exposure in a heterologous HEK293T model[J]. Int J Mol Sci, 2022, 23:8034-8034.
[5]Yang F, Yang RJ, Li Q, et al. Whole-exome sequencing facilitates the differential diagnosis of Ehlers-Danlos syndrome (EDS)[J]. Mol Genet Genomic Med, 2022, 10: e1885. doi: 10.1002/mgg3.1885.
[6]Fukada T, Civic N, Furuichi T, et al. The zinc trans-porter SLC39A13/ZIP13 is required for connective tissue development: its involvement in BMP/TGF-beta signaling pathways[J]. PLoS One, 2008, 3: e3642. doi: 10.1371/journal.pone.0003642.
[7]Hirose T, Shimazaki T, Takahashi N, et al. Morpho-metric analysis of thoracic aorta in Slc39a13/ZIP13-KO mice[J]. Cell Tissue Res, 2019, 376:137-141.
[8]Jeong J, Walker JM, Wang F, et al. Promotion of vesicular zinc efflux by ZIP13 and its implications for spondylocheiro dysplastic Ehlers-Danlos syndrome[J]. Proc Natl Acad Sci USA, 2012, 109: e3530-8. doi: 10.1073/pnas.1211775110.
[9]Yamauchi T, Hiroset T, Satok K, et al. Changes in skin structure of the Zip13-KO mouse by Makomo (Zizania latifolia) feeding[J]. J Vet Med Sci, 2017, 79:1563-1568.
[10]Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists[J]. Trends Cell Biol, 1998, 8:397-403.
[11]Dusanic M, Dekomien G, Lvcke T, et al. Novel nonsense mutation in SLC39A13 initially presenting as myopathy: case report and review of the literature[J]. Mol Syndromol, 2018, 9:100-109.
[12]Lee MG, Choi MA, Chae S, et al. Loss of the dermis zinc transporter ZIP13 promotes the mildness of fibrosarcoma by inhibiting autophagy[J]. Sci Rep, 2019, 9:15042. doi: 10.1038/s41598-019-51438-9.
[13]Cheng X, Wang J, Liu C, et al. Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway[J]. J Exp Clin Cancer Res, 2021, 40:199. doi: 10.1186/s13046-021-01999-3.
[14]陈畅, 杨淑雅, 刘宝怡,等. SLC39A13基因的泛癌分析[J]. 中国医学工程, 2022, 30: 26-33.
[15]Faukunaka A, Fukada T, Bhin J, et al. Zinc transporter ZIP13 suppresses beige adipocyte biogenesis and energy expenditure by regulating C/EBP-β expression [J]. PLoS Genet, 2017, 13: e1006950. doi: 10.1371/journal.pgen.1006950.
[16]Chen Z, Gordillo-Martinez F, Jiang L, et al. Zinc ameliorates human aortic valve calcification through GPR39 mediated ERK1/2 signalling pathway[J]. Cardiovasc Res, 2021, 117:820-835.
[17]滕天明,黄进勇,薛雨辰,等.高盐诱导左心室舒张功能障碍大鼠心肌Zip13表达增高[J].临床荟萃,2020,35:589-594.
[18]Hara T, Yamada I, Ohashi T, et al. Role of Scl39a13/ZIP13 in cardiovascular homeostasis[J]. PLoS One, 2022, 17: e0276452. doi: 10.1371/journal.pone.0276452.
[19]Lawson R, Maret W, Hogstrand C. Prolonged stimulation of insulin release from MIN6 cells causes zinc depletion and loss of β-cell markers[J]. J Trace Elem Med Biol, 2018, 49: 51-59.
[20]江天铎,程欣欣,徐哲龙.锌转运体ZIP13在小鼠肝脏缺血再灌注损伤中的作用[J].天津医科大学学报,2022,28:459-465.
[21]Sun B, Ma J, Te L, et al. Zinc-Deficient diet causes imbalance in Zinc homeostasis and impaired autophagy and impairs semen quality in mice[J]. Biol Trace Elem Res, 2023, 201:2396-2406.
[22]Wang J, Cheng X, Zhao H, et al. Downregulation of the zinc transporter SLC39A13 (ZIP13) is responsible for the activation of CaMKII at reperfusion and leads to myocardial ischemia/reperfusion injury in mouse hearts[J]. J Mol Cell Cardiol, 2021, 152:69-79.
[23]陈春梅,葛品,郭翀.人体铁代谢及其调控因素[J].基础医学与临床,2022,42:818-823.
[24]Xue J, Li G, Ji X, et al. Drosophila ZIP13 over-expression or transferrin1 RNAi influences the muscle degeneration of Pink1 RNAi by elevating iron levels in mitochondria[J]. J Neurochem, 2022, 160:540-555.

锌转运体ZIP13与疾病

Zinc transporter ZIP13 and diseases

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杜敬宇, 应站专, 侯宾, 多杰, 赵振. 抑制miR-34a减轻慢性阻塞性肺疾病急性加重期炎性反应[J]. 基础医学与临床, 2024, 44(12): 1670-1677.
[2]	李晋平, 刘汉卿, 杨全会. 大鼠严重腹腔感染后脾脏细胞周期的变化[J]. 基础医学与临床, 2024, 44(6): 828-832.
[3]	杨洋, 张雅茸, 杨红琴, 王婧, 赵红梅. 磷酸二酯酶5在心力衰竭中作用的研究进展[J]. 基础医学与临床, 2024, 44(5): 724-728.
[4]	韩丽杰, 胡朝伟, 于华惠, 秦彦文. 血管生成素样蛋白8在心血管疾病发病中作用的研究进展[J]. 基础医学与临床, 2024, 44(4): 544-547.
[5]	刘怡斐, 王鑫宇, 王嘉慧, 杜晓冰, 王途, 赵娟. 尾加压素Ⅱ受体拮抗剂(urantide)减轻动脉粥样硬化大鼠肾脏损伤[J]. 基础医学与临床, 2023, 43(11): 1668-1672.
[6]	刘磊, 丁兰, 袁媛, 叶菁. 铁超载在肝脏疾病中的研究进展[J]. 基础医学与临床, 2023, 43(6): 990-993.
[7]	钟琳, 钟洪莉, 代宇婕, 张庆华. 敲低热休克转录因子5(Hsf5)对小鼠睾丸间质细胞和支持细胞中热休克家族的影响[J]. 基础医学与临床, 2023, 43(4): 626-631.
[8]	岳秀青, 宋其泰, 刘超利, 李桑柔, 杨帆, 陈睦虎, 钟武. 生物钟蛋白CRY1抑制Ang Ⅱ诱导的小鼠主动脉平滑肌细胞表型蛋白标志物变化[J]. 基础医学与临床, 2023, 43(4): 588-595.
[9]	王芳芳, 曹慧媛, 汪婧, 王宁, 黄国良. 上调miR-200c-5p的表达抑制人结直肠癌细胞系SW480增殖[J]. 基础医学与临床, 2023, 43(2): 241-245.
[10]	郭丽苹, 苏娟, 田新雁, 陆丽, 胡亚荣, 秦燕. 骨桥蛋白在大鼠肝缺血/再灌注损伤中的作用[J]. 基础医学与临床, 2023, 43(1): 83-86.
[11]	潘明敏, 王启阳, 杨丽萍. FTO介导RNA的m6A修饰与发育的研究进展[J]. 基础医学与临床, 2022, 42(10): 1591-1595.
[12]	匡重伸, 丛竹凯, 吴长毅, 杨宁, 宗亚楠, 郭向阳. 内脂素在脓毒症相关性脏器损伤中的作用及机制研究进展[J]. 基础医学与临床, 2022, 42(8): 1279-1283.
[13]	孙秋菊, 焦晓璐, 于华惠, 李凡, 吕倩雯, 王钰, 秦彦文. 血管生成素样蛋白8促进大鼠主动脉血管平滑肌细胞表型转化[J]. 基础医学与临床, 2022, 42(5): 745-751.
[14]	梁清, 陈丽红. 生物钟紊乱致心脏功能障碍的研究进展[J]. 基础医学与临床, 2022, 42(5): 799-803.
[15]	连婷, 张瑞君, 熊晓兰, 张小雅, 余涛, 张世忠. 线粒体通透性转换孔在锌缺乏模型大鼠心肌缺血/再灌注损伤中的作用[J]. 基础医学与临床, 2022, 42(3): 389-394.